Correlated Drug Terms (7)

---

	Name (Synonyms)	Correlation
drug2990	risk factors Wiki	0.71
drug1224	Interferon-Beta Wiki	0.71
drug2263	Simvastatin Wiki	0.50
drug1612	No Intervention Wiki	0.41
drug2105	Rivaroxaban Wiki	0.41
drug1374	Losartan Wiki	0.25
drug601	Colchicine Wiki	0.25

Correlated MeSH Terms (6)

---

	Name (Synonyms)	Correlation
D016638	Critical Illness NIH	0.10
D045169	Severe Acute Respiratory Syndrome NIH	0.07
D055371	Acute Lung Injury NIH	0.07
D012127	Respiratory Distress Syndrome, Newborn NIH	0.07
D012128	Respiratory Distress Syndrome, Adult NIH	0.06
D018352	Coronavirus Infections NIH	0.06

Correlated HPO Terms (0)

---

	Name (Synonyms)	Correlation

Primary Outcomes

Description: composite of hospitalization or death

Measure: Outpatient trial - Colchicine vs. control and Aspirin vs. control

Time: 45 days post randomization

---

Description: invasive mechanical ventilation or death

Measure: Inpatient trial - Interferon-β vs. control and Colchicine vs. control

Time: 45 days post randomization

---

Description: invasive mechanical ventilation or death

Measure: Inpatient trial - Aspirin and rivaroxaban vs. control

Time: 45 days post randomization

---

Secondary Outcomes

Description: disease progression by 2 points on a 7-point scale

Measure: Outpatient and Inpatient trials - Colchicine vs. control, Interferon-β vs. control

Time: 45 days post randomization

---

Description: composite of major adverse cardiovascular events (MI, stroke, ALI, VTE, death), and disease progression by 2 points on a 7-point scale

Measure: Outpatient and Inpatient trials - Aspirin vs. control, Aspirin and rivaroxaban vs. control

Time: 45 days post randomization

---

Primary Outcomes

Description: Cause of death will be described

Measure: Death

Time: up to 28 days of randomisation

---

Secondary Outcomes

Measure: Myocardial infarction

Time: up to 28 days of randomisation

---

Measure: Congestive cardiac failure

Time: up to 28 days of randomisation

---

Measure: Severe cardiac arrythmia

Time: up to 28 days of randomisation

---

Measure: Myocarditis

Time: up to 28 days of randomisation

---

Measure: Respiratory failure including ARDS

Time: up to 28 days of randomisation

---

Measure: Viral pneumonitis

Time: up to 28 days of randomisation

---

Measure: Acute renal failure

Time: up to 28 days of randomisation

---

Measure: Sepsis

Time: up to 28 days of randomisation

---

Measure: Stroke

Time: up to 28 days of randomisation

---

Measure: Gastrointestinal bleeding

Time: up to 28 days of randomisation

---

Measure: Receipt of non invasive or mechanical ventilation

Time: up to 28 days of randomisation

---

Measure: Ability to self care at hospital discharge

Time: up to 28 days of randomisation

---